Lamivudine 150mg tabs/PAC-60
Lamivudine 150mg film coated tablets, bottle or blister pack of 60
Indicative Price : Upon Request
NOTE: The description below is for a standard product. It is not specific to patent status and pricing policies that may apply at country level. This information is available on request from Supply Division: Contact: firstname.lastname@example.org
Lamivudine 150mg film coated tablets, pack of 60
Each film coated scored tablet contains 150mg of Lamivudine
Tablets should be scored with at least one break line to allow for division of tablets into two parts, each containing the same amount of active ingredients.
Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI)
Standard shelf life:
Other available formulations:
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.
Guidelines for use:
For more details, please click the links listed below:
WHO treatment guidelines
WHO Essential Medicines Library
or your regional national guidelines
For details about paediatric dosage schemes, please click the links listed below:
WHO Generic tool for assessing paediatric ARV dosing
Management of HIV infection in combination with at least two other antiretroviral drugs. By mouth (oral) PO.
Prevention of mother to child transmission (PMTCT): In combination with other drugs in the therapy for prevention of maternal-fetal transmission of HIV.
Packaging and storage:
Do not store above 30ºC (86ºF). Store in a tightly closed container. Do not freeze.
Keep out of reach and sight of children.
Keep in original pack.
Dispense in original container. Do not repack
For latest updates, please click the links listed below:
List of WHO Prequalified Medicines
List of USFDA approved and tentatively approved items
Component of a kit
(S1400097) is a component of S9901003- IEHK 2011 PEP Kit
|To see icon descriptions, go to |
' Product attribute guide'